| 000 | 01632 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513185945.0 | ||
| 264 | 0 | _c19990812 | |
| 008 | 199908s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohan, P M | |
| 245 | 0 | 0 |
_aAdenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator receptor suppresses glioma invasion and tumor growth. _h[electronic resource] |
| 260 |
_bCancer research _cJul 1999 |
||
| 300 |
_a3369-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain Neoplasms _xpathology |
| 650 | 0 | 4 |
_aDNA, Antisense _xgenetics |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aGlioblastoma _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 | _aOrganoids |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aChintala, S K | |
| 700 | 1 | _aMohanam, S | |
| 700 | 1 | _aGladson, C L | |
| 700 | 1 | _aKim, E S | |
| 700 | 1 | _aGokaslan, Z L | |
| 700 | 1 | _aLakka, S S | |
| 700 | 1 | _aRoth, J A | |
| 700 | 1 | _aFang, B | |
| 700 | 1 | _aSawaya, R | |
| 700 | 1 | _aKyritsis, A P | |
| 700 | 1 | _aRao, J S | |
| 773 | 0 |
_tCancer research _gvol. 59 _gno. 14 _gp. 3369-73 |
|
| 999 |
_c10374615 _d10374615 |
||